Kunie Nakamura

This inventor holds 6 USPTO granted patents. Top assignees: Asai Germanium Research Institute, Sato Pharmaceutical Co., Ltd.. Active years: 1990-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kunie Nakamura. Retrieved from https://idiyas.com/inventor/kunie-nakamura

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 15(Granted Patents)

Location History:

Sagamihara, JP (1990 - 1991)
Kanagawa, JP (1992 - 1994)

Company Filing History:

6 out of 25

Asai Germanium Research Institute

patents

1 out of 18

Sato Pharmaceutical Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1990-1994

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5352815 - Agent for suppression and interception of mailard reaction (1994-10-04),

2. 5118679 - Agent for preventing and treating opacity of lens (1992-06-02),

3. 5006553 - Agent for improving reduced functions of organs caused by inhibited (1991-04-09),

4. 4977287 - Organogermanium compounds and process for producing the same (1990-12-11),

5. 4956272 - Organogermanium containing solution for washing and storing separated (1990-09-11),

6. 4919917 - Agent for reducing nephrotoxicity caused by cyclosporin administration (1990-04-24),

Title: Kunie Nakamura: Innovator in Organic Germanium Compounds

Introduction

Kunie Nakamura is a prominent inventor based in Sagamihara, Japan. She has made significant contributions to the field of organic germanium compounds, holding a total of six patents. Her innovative work focuses on applications that enhance health and safety.

Latest Patents

Among her latest patents is an agent for suppression and interception of the Maillard reaction. This invention provides an effective solution that comprises an organogermanium compound, which can suppress or intercept the Maillard reaction while ensuring high safety for long-term administration. Another notable patent is an agent for preventing and treating opacity of the lens. This agent contains the organic germanium compound and is designed to be highly effective in treating lens opacity, showcasing her commitment to advancing medical solutions.

Career Highlights

Throughout her career, Kunie Nakamura has worked with reputable organizations such as Asai Germanium Research Institute Co., Ltd. and Sato Pharmaceutical Co., Ltd. Her work in these companies has allowed her to develop and refine her innovative ideas, contributing to her success as an inventor.

Collaborations

Kunie has collaborated with notable individuals in her field, including Norihiro Kakimoto and Kazuo Kumano. These partnerships have further enriched her research and development efforts.

Conclusion

Kunie Nakamura's contributions to the field of organic germanium compounds highlight her innovative spirit and dedication to improving health outcomes. Her patents reflect her expertise and commitment to advancing scientific knowledge.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]